Net sales: JPY 1265.5 billion, up 2% YoY
Operating income: JPY 101.0 billion, up 7%
Exceed JPY 100 billion, first time for Meiji Group
Net income
Significant jump due to the gain from negative goodwill raised from KM Biologics
Need cash for capital expenditures (boost investment)
Dividend: Closely examine business performance in the Second Half
Net sales: JPY 1265.5 billion, up 2% YoY
Operating income: JPY 101.0 billion, up 7%
Exceed JPY 100 billion, first time for Meiji Group
Net income
Significant jump due to the gain from negative goodwill raised from KM Biologics
Distribution of surplusNeed cash for capital expenditures (boost investment)
Dividend: Closely examine business performance in the Second Half